Effect of 360° VR and 2D Videos on Patient Anxiety in Outpatient Ophthalmologic Care

NCT07530120 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-04-15

No results posted yet for this study

Summary

Background Previous research on ambulatory care pathways has highlighted recurring issues such as elevated patient anxiety, disorientation, and insufficient access to information, all of which negatively affect the patient experience. However, evidence remains limited regarding the effectiveness of different preparatory media in mitigating these issues in real-world clinical settings.

Objectives The present study aims to assess whether viewing a video of an outpatient ophthalmologic care pathway prior to the day of surgery-either as a standard 2D video or as a 360° immersive video experienced in virtual reality (VR)-reduces patient anxiety and disorientation compared with a control condition without media support. In addition, the study aims to determine which medium is most effective and to explore methods for assessing anxiety, orientation, and information in ecological clinical settings.

Conditions

  • Preoperative Anxiety
  • Virtual Reality

Interventions

OTHER

Watching a video of the outpatient care pathway

Before surgery, patients watch an informational video explaining the outpatient journey at IOO Jules Verne.

OTHER

No viewing of the video

The control group does not view the video and receives only verbal information delivered by the administrative staff.

Sponsors & Collaborators

  • Nantes University

    collaborator UNKNOWN
  • Institut Ophtalmologique de l'Ouest Jules Verne

    lead OTHER

Principal Investigators

  • Frank BECQUET, Docteur · Institut Ophtalmologique de l'Ouest Jules Verne

  • Jean Philippe RIVIERE, Maître de conférences · Laboratoire des Sciences du Numérique de Nantes UMR-6004

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2026-02-09
Completion
2026-02-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07530120 on ClinicalTrials.gov